Scientific stakeholders


  1. Dr Tamara Saksida, Institute for Biological Research "Siniša Stanković", National Institute of the Republic of Serbia, Bulevar despota Stefana 142, Belgrade, Serbia. Contact:
  2. Prof. Dr. Milica Popović, Faculty of Chemistry, University of Belgrade, Serbia, Studentski Trg 12-16, Belgrade, Serbia. Contact:
  3. Prof. Dr. Ana Banko, Faculty of Medicine, University of Belgrade, Serbia, Dr Subotica 8, Belgrade, Serbia. Contact:
  4. Prof. Dr. Aleksandra Buha Đorđević, Faculty of Pharmacy, University of Belgrade, Serbia, Vojvode Stepe 450, Belgrade, Serbia. Contact:
  5. Prof Dr Zeljko Popovic, Department of Biology and Ecology, Faculty of Sciences, University of Novi Sad, Trg Dositeja Obradovića 3, Novi Sad, Serbia. Contact:
  6. Prof Dr Katarina Savić-Vujović, Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Serbia. Contact:
  7. Prof Dr Jelena Milašin, Department of Biology with Human Genetics, Faculty of Dental Medicine University of Belgrade, Serbia. Contact:
  8. Prim. Dr Davorin Radosavljević, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia. Contact:
  9. Prof. Dr. Antoni Castells, Gastrointestinal and Pancreatic Oncology Team, Clínic Barcelona, University of Barcelona, FRCB-IDIBAPS, Barcelona, Spain. Contact:
  10. Prof. Dr. Jordi Camps, Translational Colorectal Cancer Genomics Group, Autonomous University of Barcelona, FRCB-IDIBAPS, Barcelona, Spain. Contact:
  11. Dr. Veronika Vymetalkova, Academy of Sciences of the Czech Republic, Prague, Czech Republic. Contact:
  12. Prof. Dr. Nikolas Stoecklein, Heinrich-Heine-Universität Düsseldorf, Universitätsklinikum Düsseldorf, Düsseldorf, Germany. Contact:
  13. Prof. Dr. Marc Gunter, Imperial College London, International Agency for Research on Cancer (IARC), Lyon, France. Contact:
  14. Prof. Dr. Olga Abian, Institute for Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, Zaragoza, Spain. Contact:
  15. Dr Alexei Levitchi, Department of Molecular biology and Human genetics, State University of Medicine and Pharmacy "Nicolae Testemitanu" Chișinău, Moldova   Contact:
  16. Dr Simon Furney, University of Medicine and Health Sciences, Dublin, Ireland. Contact:
  17. Prof. Evi Lianidou, Laboratory of Analytical Chemistry, Analysis of Circulating Tumor Cells (ACTC) Lab, Dept. of Chemistry, National and Kapodistrian University of Athens, Athens, Greece. Contact: email:

Associations and Institutes

  1. Association of Digestive Oncology of Serbia, Dr Koste Todorovića 6, Belgrade, Serbia. Contact:
  2. Association of Medical Oncologists of Serbia, Pasterova 14, Belgrade, Serbia, Contact:
  3. Serbian Society for Extracellular Vesicles, Prvomajska 44, Belgrade, Serbia, Contact:
  4. Serbian Genetics Society, Slobodana Bajića 1, Belgrade, Serbia. Contact:
  5. Asociación Española de Gastroenterología (AEG), Sor Ángela de la Cruz, 8, 1ºA, 28020 Madrid, Spain. Contact:
  6. Societat Catalana de Digestologia (SCD). Acadèmia de Ciències Mèdiques i de la Salut de Catalunya i de Balears. Major de Can Caralleu 1-7, 08017 Barcelona, Spain. Contact:
  7. Asociación Española de Investigación sobre el Cáncer (ASEICA), Passatge Batlló 15, 08036 Barcelona, Spain. Contact:
  8. Asociación Española de Genética Humana (AEGH). Universitat nº4, 4º, 4, 46003 Valencia, Spain. Contact:
  9. National and Kapodistrian University of Athens, Panepistimiou 30, Athens, Greece Contact:,
  10. Center for the Promotion of Science, 46 Kralja Petra Street, 11158 Belgrade, Republic of Serbia   Contact:
  11. Macedonian Academy of Sciences and Arts, Skopje, Republic of Macedonia. Contact: Dr Katarina Devalieva,
  12. Centre for the Fourth Industrial Revolution, Katićeva 14, Belgrade, Serbia. Contact:
  13. Health RI, Beatrixgebouw Jaarbeurs, HI-FIVE: 5th floor, Jaarbeursplein 6, Utrecht, the Netherlands. Contact:
  14. Hellenic Society for Liquid Biopsy. National and Kapodistrian University of Athens, Athens, Greece. Contact:


  1. GenoLab, Laboratory for Medical Biochemistry and Molecular Diagnostics, Kosovska 7, Novi Sad, Serbia, contact:
  2. STAB VIDA, LDA. Madan Parque, Rua dos Inventores, Salas 2.18 e 2.19, 2825-182 Caparica - Portugal, contact: Dr Orfeu Flores, CEO,
  3. Dreangenics, Finlandia, 2, 1º, 33010 Oviedo, Spain. Contact:
  4. COBIOMIC BIOSCIENCE, Parque Cienbtífico Tecnológico de Córdoba, Rabanales 21, Calle Astrónoma Cecília Payne ID 8.1, Edif. Centauro, 14014 Córdoba, Spain. Contact:
  5. EXELIXIS Research Management & Communication, Kleisthenous 187, 153 44, Athens, Greece Contact:,
  6. Biosample Hub, The Old School, The Quay, Carmarthen, SA31 3LN, UK. Contact:
  7. NOVOS d.o.o.Partnership through science. Cara Dušana 207, 11080 Belgrade, Serbia. Contact:
  8. Genial. Kneginje Zorke 2, Belgrade, Serbia. Contact:
  9. Visaris, Batajnički drum 10. 1B, Belgrade, Serbia. Contact:
  10. Personal Genome Diagnostics/LabCorp. 3600 Boston Street, Suite 10. Baltimore, MD, USA. Contact:

Twinning projects

  1. Twinning for new Graphene-based Composites in Electromagnetic Interference Shielding, GrInShield. Grant agreement ID: 101079151, Contact: Coordinator: Dr Svetlana Jovanovic,
  2. Twinning to excel materials engineering for medical devices, ExcellMater, Grant agreement ID: 952033. Contact: Coordinator: Prof Dr Bojana Obradovic,
  3. BOOSting excellence in environmental EPIgenetics, EPIBOOST, Grant agreement ID: 101078991. Contact: Coordinator: Dr Joana Pereira,
  4. Enhancement of Scientific Excellence and Innovation Potential in Electronic Instrumentation for Ionizing Radiation Environments, ELICSIR, Grant agreement ID: 857558. Contact: Coordinator: Prof Dr Goran Ristic,
  5. Boosting Institute of Chemistry Technology and Metallurgy in Water Biomonitoring, BIOLAWEB, Grant agreement ID: 101079234.
    Coordinator: Dr Milos Ciric,
  6. Twinning for reaching sustainable scientific and technological excellence in the field of Green Electronics. GREENELIT - 951747. Coordinator: Prof. Dr Goran Stojanović. Contact:

Other Projects from the field

  1. Modulation of gut ILC3 cells by a FFAR2 agonist for the treatment of autoimmune diseases (GUTtoAID, Science Fund of the Republic of Serbia, IDEJE).
    Coordinator: Dr Djordje Miljkovic, Department of Immunology, Institute for Biological Research "Siniša Stanković" University of Belgrade, Serbia.
  2. Discovering the causes of three poorly understood cancers in Europe (Horizon Europe Mission on Cancer, DISCERN).
    Coordinators: Dr Paul Brennan, Dr Marc Gunter. International Agency for Research on Cancer.
  3. The enigmatic role of Epstein-Barr virus infection in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Which viral marker could suggest triggering of autoimmune diseases? (ROLERS, Science Fund of the Republic of Serbia, PROMIS).
    Coordinator: Prof. Dr Ana Banko, Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Serbia.

Patient advocate associations

  1. Digestive Cancers Europe, vzw/asbl, Rue de la Loi 235/27, 1040 Brussels, Belgium. Contact:
  2. Asociación Española contra el Cáncer (AECC), Teniente Coronel Noreña, 30, 28045 Madrid, Spain. Contact:
  3. Asociación de familias con Síndrome de Lynch (AFALYNCH), Calle de Nicaragua 48, 08029 Barcelona, Spain. Contact:
  4. Patients Association of Serbia. Oračka 29, Belgrade, Serbia. Contact:
  5. Center for palliative care and palliative medicine “BELhospice. 20. October 12a, Belgrade, Serbia. Contact: